ARCHIVES

FDA Approves Avastin For Recurrent NSCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Programs: BSA Approves Formation Of Two Grant Programs:

July 2, 1999

NCI Buys Building For PDQ, ICRDB With Donated Money

December 10, 1982

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Hyperthermia Offers Prospects For Major Treatment Advance, Investigators Says

March 11, 1977

Platinum-Free Break Enhances Therapy After First Relapse In Ovarian Cancer

March 28, 2003

University of Pittsburgh honors breast cancer surgeon and clinical trialist Bernard Fisher with lecture and portrait.

May 13, 2005